Discover the most effective weight loss tool on the market.

The same active ingredient as Mounjaro® and Zepbound™.

People using Tirzepatide lose more weight than any other GLP-1 product. Patients lose on average 22.5% of body weight in 72 weeks.

Skip to product information
1 of 1

GLP-1 + GIP Therapy for Weight Loss

Tirzepatide

Tirzepatide

Tirzepatide is an injectable medicine used for weight loss, and is the FDA-approved ingredient in the popular drugs Zepbound™ and Mounjaro®.

Tirzepatide regulates blood sugar, makes you feel full for longer, controls feelings of hunger and craving in the brain, and helps regulate fat cells and adiposity. 

Requires Telehealth consult and a prescription.

  • Effective Home Therapy
  • Simple Online Evaluation
  • Unlimited Doctor Messaging
  • USA Licensed Pharmacies
  • No Insurance Required
  • Exercise and Diet Support
Regular price $690
Regular price Sale price $690
Sale Sold out
Size
View full details

Speak with one of our health coaches to learn more about this program.

Benefits

  • Curbs appetite and cravings

  • Helps regulate blood sugar

  • Increases insulin secretion

  • Study participants lost up to 15% of their body weight in one year
  • Online Forms

    Check out with your desired plan and complete the online health history forms.

  • Doctor Review

    Licensed medical staff review your forms and prescribe your selected therapy if applicable.

  • Treatment at Home

    Personalized treatments ship to your door with everything you need. Meet with your care team as needed.

Safety Considerations

Tirzepatide is FDA-approved under the brand names Zepbound and Mounjaro. Levers.Health provides compounded Tirzepatide from USA-licensed and regulated 503A pharmacies only.

Severe side effects are possible with any drug. Please read the FULL SAFETY CARD for Tirzepatide here.

Do not use Tirzepatide if you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC).

Do not use Tirzepatide if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

Do not use Tirzepatide if you have had a serious allergic reaction to tirzepatide or any of the ingredients in Tirzepatide.

Common side effects:

The most common side effects of Tirzepatide include nausea, diarrhea, vomiting, constipation, stomach (abdominal) pain, indigestion, injection site reactions, feeling tired, allergic reactions, belching, hair loss, and heartburn. These are not all the possible side effects of Tirzepatide. Talk to your healthcare provider about any side effect that bothers you or doesn’t go away.